Crizotinib-Related Aseptic Abscesses in Lung Adenocarcinoma and <i>ROS1</i>-Gene Rearrangement: A Case Report

Crizotinib is a multi-tyrosine kinase inhibitor (mTKI) with efficacy in treating c-ROS oncogene 1-positive non-small cell lung cancer (NSCLC). The association between this TKI and the development of renal cysts is well established, although data on the formation of aseptic abscesses is scarce. We re...

Full description

Saved in:
Bibliographic Details
Main Authors: Thamires Oliveira-Silva, Camila Naegele-Bazzanella, Mauro Zukin, Nicolle Cavalcante, Antônio Alexandre de-Oliveira-Siciliano, Jaime Araújo-Oliveira-Neto, Clarissa Baldotto
Format: Article
Language:English
Published: Thieme Revinter Publicações Ltda. 2025-01-01
Series:Brazilian Journal of Oncology
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1805098
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850109746449743872
author Thamires Oliveira-Silva
Camila Naegele-Bazzanella
Mauro Zukin
Nicolle Cavalcante
Antônio Alexandre de-Oliveira-Siciliano
Jaime Araújo-Oliveira-Neto
Clarissa Baldotto
author_facet Thamires Oliveira-Silva
Camila Naegele-Bazzanella
Mauro Zukin
Nicolle Cavalcante
Antônio Alexandre de-Oliveira-Siciliano
Jaime Araújo-Oliveira-Neto
Clarissa Baldotto
author_sort Thamires Oliveira-Silva
collection DOAJ
description Crizotinib is a multi-tyrosine kinase inhibitor (mTKI) with efficacy in treating c-ROS oncogene 1-positive non-small cell lung cancer (NSCLC). The association between this TKI and the development of renal cysts is well established, although data on the formation of aseptic abscesses is scarce. We report a case of a patient with ROS1-positive NSCLC treated with crizotinib who developed multiple renal and extrarenal cysts and aseptic abscesses associated with a quick resolution of these lesions after the discontinuation of the TKI therapy. We aim to report a rare presentation of a drug-related adverse event with an unusual behavior.
format Article
id doaj-art-4891a3b6536b4714a38d8a6da8f54e9e
institution OA Journals
issn 2526-8732
language English
publishDate 2025-01-01
publisher Thieme Revinter Publicações Ltda.
record_format Article
series Brazilian Journal of Oncology
spelling doaj-art-4891a3b6536b4714a38d8a6da8f54e9e2025-08-20T02:37:59ZengThieme Revinter Publicações Ltda.Brazilian Journal of Oncology2526-87322025-01-012110.1055/s-0045-1805098Crizotinib-Related Aseptic Abscesses in Lung Adenocarcinoma and <i>ROS1</i>-Gene Rearrangement: A Case ReportThamires Oliveira-Silva0https://orcid.org/0009-0003-4825-5475Camila Naegele-Bazzanella1https://orcid.org/0009-0002-4719-0502Mauro Zukin2https://orcid.org/0000-0002-6439-3136Nicolle Cavalcante3https://orcid.org/0000-0001-7597-3286Antônio Alexandre de-Oliveira-Siciliano4https://orcid.org/0009-0007-2554-9250Jaime Araújo-Oliveira-Neto5https://orcid.org/0000-0003-0044-7622Clarissa Baldotto6https://orcid.org/0000-0001-9539-3094Department of Clinical Oncology, Instituto D'OR de Pesquisa e Ensino, Rio de Janeiro, RJ, BrazilDepartment of Clinical Oncology, Instituto D'OR de Pesquisa e Ensino, Rio de Janeiro, RJ, BrazilDepartment of Clinical Oncology, Instituto D'OR de Pesquisa e Ensino, Rio de Janeiro, RJ, BrazilDepartment of Pathology, Instituto D'OR de Pesquisa e Ensino, Rio de Janeiro, RJ, BrazilDepartment of Radiology, Instituto D'OR de Pesquisa e Ensino, Rio de Janeiro, RJ, BrazilDepartment of Radiology, Instituto D'OR de Pesquisa e Ensino, Rio de Janeiro, RJ, BrazilDepartment of Clinical Oncology, Instituto D'OR de Pesquisa e Ensino, Rio de Janeiro, RJ, BrazilCrizotinib is a multi-tyrosine kinase inhibitor (mTKI) with efficacy in treating c-ROS oncogene 1-positive non-small cell lung cancer (NSCLC). The association between this TKI and the development of renal cysts is well established, although data on the formation of aseptic abscesses is scarce. We report a case of a patient with ROS1-positive NSCLC treated with crizotinib who developed multiple renal and extrarenal cysts and aseptic abscesses associated with a quick resolution of these lesions after the discontinuation of the TKI therapy. We aim to report a rare presentation of a drug-related adverse event with an unusual behavior.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1805098aseptic abscessescrizotiniblung cancerROS1 rearrangementkidney cysts
spellingShingle Thamires Oliveira-Silva
Camila Naegele-Bazzanella
Mauro Zukin
Nicolle Cavalcante
Antônio Alexandre de-Oliveira-Siciliano
Jaime Araújo-Oliveira-Neto
Clarissa Baldotto
Crizotinib-Related Aseptic Abscesses in Lung Adenocarcinoma and <i>ROS1</i>-Gene Rearrangement: A Case Report
Brazilian Journal of Oncology
aseptic abscesses
crizotinib
lung cancer
ROS1 rearrangement
kidney cysts
title Crizotinib-Related Aseptic Abscesses in Lung Adenocarcinoma and <i>ROS1</i>-Gene Rearrangement: A Case Report
title_full Crizotinib-Related Aseptic Abscesses in Lung Adenocarcinoma and <i>ROS1</i>-Gene Rearrangement: A Case Report
title_fullStr Crizotinib-Related Aseptic Abscesses in Lung Adenocarcinoma and <i>ROS1</i>-Gene Rearrangement: A Case Report
title_full_unstemmed Crizotinib-Related Aseptic Abscesses in Lung Adenocarcinoma and <i>ROS1</i>-Gene Rearrangement: A Case Report
title_short Crizotinib-Related Aseptic Abscesses in Lung Adenocarcinoma and <i>ROS1</i>-Gene Rearrangement: A Case Report
title_sort crizotinib related aseptic abscesses in lung adenocarcinoma and i ros1 i gene rearrangement a case report
topic aseptic abscesses
crizotinib
lung cancer
ROS1 rearrangement
kidney cysts
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1805098
work_keys_str_mv AT thamiresoliveirasilva crizotinibrelatedasepticabscessesinlungadenocarcinomaandiros1igenerearrangementacasereport
AT camilanaegelebazzanella crizotinibrelatedasepticabscessesinlungadenocarcinomaandiros1igenerearrangementacasereport
AT maurozukin crizotinibrelatedasepticabscessesinlungadenocarcinomaandiros1igenerearrangementacasereport
AT nicollecavalcante crizotinibrelatedasepticabscessesinlungadenocarcinomaandiros1igenerearrangementacasereport
AT antonioalexandredeoliveirasiciliano crizotinibrelatedasepticabscessesinlungadenocarcinomaandiros1igenerearrangementacasereport
AT jaimearaujooliveiraneto crizotinibrelatedasepticabscessesinlungadenocarcinomaandiros1igenerearrangementacasereport
AT clarissabaldotto crizotinibrelatedasepticabscessesinlungadenocarcinomaandiros1igenerearrangementacasereport